BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 3005508)

  • 1. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride.
    Battaglia G; Norman AB; Hess EJ; Creese I
    J Neurochem; 1986 Apr; 46(4):1180-5. PubMed ID: 3005508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influences of pertussis toxin, guanine nucleotides and forskolin on adenylate cyclase in striatal membranes of infant, adult and senescent rats.
    Nomura Y; Arima T; Swgawa T
    Int J Dev Neurosci; 1987; 5(3):271-9. PubMed ID: 3503504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NaF and guanine nucleotides modulate adenylate cyclase activity in NG108-15 cells by interacting with both Gs and Gi.
    Kelly E; Keen M; Nobbs P; MacDermot J
    Br J Pharmacol; 1990 Jun; 100(2):223-30. PubMed ID: 1696150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis toxin attenuates D2 inhibition and enhances D1 stimulation of adenylate cyclase by dopamine in rat striatum.
    Olianas MC; Onali P
    J Neurochem; 1987 May; 48(5):1443-7. PubMed ID: 2951497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol esters increase GTP-dependent adenylate cyclase activity in rat brain striatal membranes.
    Olianas MC; Onali P
    J Neurochem; 1986 Sep; 47(3):890-7. PubMed ID: 3734803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
    Cooper DM; Bier-Laning CM; Halford MK; Ahlijanian MK; Zahniser NR
    Mol Pharmacol; 1986 Feb; 29(2):113-9. PubMed ID: 3005824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detergent-induced distinctions between fluoride- and vanadate-stimulated adenylate cyclases and their responses to guanine nucleotides.
    Combest WL; Johnson RA
    Arch Biochem Biophys; 1983 Sep; 225(2):916-27. PubMed ID: 6556048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach.
    Coronas V; Krantic S; Jourdan F; Moyse E
    Neuroscience; 1999 Apr; 90(1):69-78. PubMed ID: 10188934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of guanine nucleotides and divalent cations on forskolin activation of rabbit luteal adenylyl cyclase: evidence for the existence of an inhibitory guanine nucleotide-binding regulatory component.
    Abramowitz J; Campbell AR
    Endocrinology; 1984 Jun; 114(6):1955-62. PubMed ID: 6327229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
    Onali P; Olianas MC
    Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forskolin-activated adenylate cyclase. Inhibition by guanyl-5'-yl imidodiphosphate.
    Hudson TH; Fain JN
    J Biol Chem; 1983 Aug; 258(16):9755-61. PubMed ID: 6684115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on [3H]SCH23390 and [3H]forskolin binding in rat striatum.
    Norman AB; Wachendorf TJ; Sanberg PR
    Life Sci; 1989; 44(13):831-6. PubMed ID: 2648096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forskolin regulation of liver membrane adenylyl cyclase.
    Birnbaumer L; Stengel D; Desmier M; Hanoune J
    Eur J Biochem; 1983 Oct; 136(1):107-12. PubMed ID: 6604628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum.
    Battaglia G; Norman AB; Hess EJ; Creese I
    Neurosci Lett; 1985 Aug; 59(2):177-82. PubMed ID: 2932659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional inhibition of forskolin-activated adenylate cyclase by guanosine diphosphate and its analog.
    Ho RJ; Shi QH; Ruiz J
    Arch Biochem Biophys; 1986 Nov; 251(1):148-55. PubMed ID: 3024569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of adenylate cyclase by dopamine, GTP, NaF and forskolin in striatal membranes of neonatal, adult and senescent rats.
    Nomura Y; Makihata J; Segawa T
    Eur J Pharmacol; 1984 Nov; 106(2):437-40. PubMed ID: 6543337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.